T
TELA
Tela Bio, Inc.
0.8901
-0.0324-3.51%After Hours: 0.9300 +0.0399 +4.48%17:31 05/22 EDT
OPEN/PREV CLOSE0.9100/0.9225
TODAY RANGE0.8601-0.9200
VOL95.67K
MARKET CAP39.85M
52 WEEK RANGE0.5011-2.200
AVG VOL (3M)179.92K
% TURNOVER0.21%
TURNOVER--
P/E (TTM)-1.1164
% RANGE6.49%
EPS(TTM)-0.7973
P/E(FORWARD)-1.3486
P/B-7.6601
BVPS-0.1162
DIVIDEND--
P/S0.4938
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP36.11M
SHARES OUTSTANDING44.77M
NEXT EARNINGS08/10-08/14
FREE FLOAT40.57M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·4d ago
Tela Bio Eyes Second-Half Ramp After Mixed Quarter
TipRanks·05/14 00:11
Tela Bio Earnings Call Balances Momentum and Risk
TipRanks·05/13 13:37
Lake Street Keeps Their Buy Rating on TELA Bio (TELA)
Seeking Alpha·05/13 00:52
TELA outlines at least 8% 2026 revenue growth while guiding Q2 revenue to about $20.0M
Benzinga·05/12 21:30
TELA Bio Q1 2026 Earnings Call Transcript
Benzinga·05/12 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·05/12 20:43
TELA Bio posts modest Q1 growth, maintains 2026 outlook
Seeking Alpha·05/12 20:34
TELA Bio GAAP EPS of -$0.21 misses by $0.02, revenue of $19.1M beats by $0.1M
Reuters·05/12 20:21
TELA Bio Q1 revenue growth beats estimates, loss widens
Dow Jones·05/12 20:16
*TELA Bio Sees 2Q Rev $20M >TELA
Dow Jones·05/12 20:15
*TELA Bio Backs FY26 Revenue Guidance of at Least 8% Growth Over FY25 >TELA
Benzinga·05/12 20:09
TELA Bio FY2026 Revenue expected to be more than $86.697M vs $86.849M Est